Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Antibiotics 2019

Sessions/ Tracks

After a successful conference of Antibiotics 2018, we are currently bringing forth “6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2019) slated on June 03-04, 2019 at London, UK. Antibiotics 2019 aims to gather the most elegant societies and industries along with the renowned and honorable persons from top universities across the globe.

Antibiotics 2019 covers various aspects of Antibiotics, The Emergence of Antimicrobial resistance,  Different Types of Antibiotics, Applications of Antibiotics, Antibiotic Resistance: Opportunities and Challenges, Antibiotics for Various Diseases and Infections, Antibiotic Prophylaxis, Antibiotics: In Pregnancy and Lactation, Antibiotics in Different Industries, Modern Antibiotics: Emerging trends, Barriers and Opportunities, Drug Discovery and Novel Delivery Technologies, Antibiotics for Emerging and Re-emerging Diseases, Micro Organisms in Recent Drug Discovery, Clinical Trials of Antibiotics, Antibiotics and Mechanism, Antibiotic Regulatory Affairs and Antibiotics Market Analysis and Business Opportunities.

Track 1: Antibiotics

Antibiotics are a type of antimicrobials that are used in treatment and prevention of bacterial infections. They may kill or inhibit the growth of bacteria. Many antibiotics are also effective against protozoans and fungi; some are toxic to humans and animals also, even when given in therapeutic dosage. Antibiotics are not effective against viruses such as common cold or influenza, and may be harmful when taken inappropriately. Physicians must ensure the patient has a bacterial infection before prescribing antibiotics.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 2: The Emergence of Antimicrobial Resistance

Antibiotic resistance invoke especially to the resistance to antibiotics that occurs in common bacteria that cause infection. The easy approach and capability of Antibiotics led to overuse in live-stock raising promotes bacteria to flourish resistance. This led to comprehensive problems with antibiotic resistance. World Health Organization (WHO) classified antimicrobial resistance as a serious hazard and no longer a indicator for the future.  Antibiotic resistance is now among every part of the world and its stirring everyone irrespective to the age. When infections become resistant to first-line drugs, more costly therapies must be used. A longer duration of illness and treatment, often in hospitals, increases health care costs as well as the financial burden on families and societies. To help prevent the development of current and future bacterial resistance, it is essential to prescribe antibiotics according to the principles of antimicrobial stewardship, such as specify antibiotics only when they are needed.   

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 3: Antibiotic Resistance: Opportunities and Challenges

Certain bacterial infections now oppose all antibiotics. The resistance problem may be reversible, but only if society begins to acknowledge how the drugs affect "good" bacteria as well as "bad". Historically, most antibacterials were used in hospitals, where they were integrated into surgical clothes and soaps to limit the spread of infection. More recently, however, those substances (including  triclosan, triclocarbon and such quaternary ammonium compounds as benzalkonium chloride) have been mixed into lotions, dish-washing detergents and soaps meant for general consumers. They have also been impregnated into such items as cutting boards, toys, high chairs and mattress pads. 

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 4: Different Types of Antibiotics

Antibiotics are also noted as antibacterials, are types of medications that destroy or slow down the growth of bacteria. Alexander Fleming discovered first penicillin, the first chemical compound with antibiotic properties. Some of the common antibiotics are Aminoglycosides, Cephalosporins, Carbapenems, Macrolides, Penicillin, Quinolones, Sulfonamides and, Tetracyclines etc. General fundamentals of antibiotic prescribing are use: First-line antibiotics first, Reserve broad spectrum antibiotics for marked circumstances only, prescribe antibiotics for bacterial infections if Symptoms are significant or severe.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 5: Applications of Antibiotics

Choice of relevant antibiotics is presently based on individual patient need.  Preservation of bacterial sensitivity needs perceptive of how antibiotics select resistance. ‘Ten commandments’ which might be considered carefully when a preference has to be made for antibiotic prescribing.  The compelling importance of the fact that all healthcare personnel should take ownership of the need to specify accordingly and to practice effective infection control.  A realization that antibiotics may not be competent for the tasks required of them and eventually, with widespread resistance, may be incapable of the task they do today.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

 Track 6: Antibiotics for Various Diseases and Infections

Antibiotics are amidst the most regularly recommended medications in modern medicine. Antibiotics are useless against viral infections. When you take antibiotics, follow the guidelines carefully. It is important to finish your medicine even if you feel improved. If you stop treatment too soon, some bacteria may survive and re-infect you. Do not save antibiotics for later or use someone else's prescription.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 7: Antibiotic Prophylaxis

Antimicrobial prophylaxis is generally used by clinicians for the prevention of numerous infectious diseases. Optimal antimicrobial agents for prophylaxis should be nontoxic, inexpensive, bactericidal and active against the typical pathogens that can motive surgical site infection postoperatively. To maximize its effectiveness, intravenous perioperative prophylaxis should be carried out within 30 to 60 minutes before the surgical incision. Antimicrobial prophylaxis should be of short time to downturn toxicity and antimicrobial resistance and to reduce cost.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 8: Antibiotics: In Pregnancy and Lactation

Antibiotics are frequently recommended during pregnancy. The specific medication must be chosen carefully, however. Some antibiotics are prescribed to take during pregnancy, while others are not. Safety depends on various factors, including the type of antibiotics, when in pregnancy you take the antibiotic, how much you take and for how long. Antibiotics normally advised safe during pregnancy:  Ampicillin, Amoxicillin, Clindamycin, Erythromycin, Penicillin, Nitrofurantoin. Despite there's no direct clue that these antibiotics cause birth defects, additional research is needed. In the interim, use of these medications is still assured in some cases.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

 Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 9: Antibiotics in Different Industries

Antibiotics must be used accordingly in humans and animals because both uses share to the emergence, persistence, and escalation of resistant bacteria. Resistant bacteria in food-producing animals are of particular concern. Food animals play as a source of resistant pathogens and resistance mechanisms that can directly or indirectly result in antibiotic resistant infections in humans. Resistant bacteria may be transmitted to humans through the foods we eat. Some bacteria have turned resistant to more than one sort of antibiotic, which makes it more difficult to treat the infections they cause. Sustaining the efficiency of antibiotic drugs is vital to insulating human and animal health.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 11: Drug Discovery and Novel Delivery Technologies

In the prior most drugs have been invented either by identifying the active ingredient from traditional remedies or by serendipitous discovery. A new access has been to recognize how disease and infection are controlled at the molecular and physiological level and to mark specific entities based on this knowledge. The process of drug discovery involves the identification of candidates, characterization, screening, synthesis, and assays for therapeutic efficacy. Evolution of an existing drug molecule from a ordinary form to a novel delivery system can significantly improve its performance in terms of patient compliance, efficacy and safety. These days, drug delivery companies are engaged in the development of numerous platform technologies to get ambitious advantage, extend patent life, and increase market share of their products. Formerly a compound has displayed its value in these tests; it will begin the process of drug development prior to clinical trials.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 12: Antibiotics for Emerging and Re-emerging Diseases

New diseases are originating globally and old diseases are re-emerging as Infectious agents evolve or spread, and as changes occur in conservation, socio-economic conditions, and population patterns. Likewise, many diseases thought to be decently controlled appear to be making a revival. In developed countries, public health measures such as sewage treatment, vaccination programs, sanitation and access to good medical care-including a wide range of antibiotics-have virtually disposed traditional diseases such as tuberculosis, diphtheria and whooping cough.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 13: Micro Organisms in Recent Drug Discovery

Environmental microbes are a leading source of drug discovery, and several microbial products (anti-tumor products, antibiotics, immune suppressants and others) are used frequently for human therapies. Most of these products were accessed from cultivable (<1%) environmental microbes, means that the large number of microbes were not targeted for drug discovery. With the onset of new and emerging technologies, we are poised to harvest novel drugs from the so-called 'uncultivable' microbes. Multidisciplinary way of linking different technologies can assist and reform drug discovery from uncultivable microbes and inspect the current cramp of technologies and scenario to swamp such constraints that might further expand the promise of drugs from environmental microbes.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 14: Clinical Trials of Antibiotics

Prescribing doctors are, progressively, using clinical trial data as a major source of information for evidence-based medicine for the remedy of infectious diseases, as in other clinical disciplines. However, it may be difficult to excerpt from these data the material that is needed for the management of the individual patient. At the same time, clinical trial testimony have been used, probably satisfactorily, in the process of drug registration, and the pharmaceutical industry has spent progressively large amount of money to satisfy the needs of this process. In the face of all these problems, switch in the way antibiotic clinical trials are designed and performed are clearly necessary, although this must not disturb the balance so far as to restore them less useful for those who currently derive greatest benefit from them.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 15: Antibiotics and Mechanism of Action

Antibacterial action customarily falls within one of four mechanisms, three of which involve the inhibition or regulation of enzymes tangled in cell wall biosynthesis, nucleic acid metabolism and repair, or protein synthesis, respectively. The fourth mechanism associates the interruption of membrane structure. Many of these cellular functions targeted by antibiotics are most effective in multiplying cells. Since there is often overlap in these functions between eukaryotic mammalian cells and prokaryotic bacterial cells, it is not surprising that some antibiotics have also been found to be useful as anticancer agents.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 16: Antibiotic Regulatory Affairs

 Regulatory affairs (RA), are also called as government affairs, is a profession within regulated industries, such as medical devices, pharmaceuticals etc. Regulatory affairs also have a very specific meaning within the healthcare industries (medical devices, functional foods, biologics and pharmaceuticals). Regulatory affairs (medical affairs) professionals (aka regulatory professionals) generally have the duty for the following general areas: Ensuring that the companies obey with all of the regulations and laws pertaining to their business.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 17: Antibiotics: Market Analysis and Business Opportunities

The global antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%. From, 2005 this market is seen to grow at an annual rate of 6.6% until 2011. There are many companies producing antibiotics these days and there are many other antibiotics present in the market such as aminoglycoside antibiotics and it cap around 79% of the global demand. Moreover, the other antibiotics such as penicillin have 8%, streptomycin 1%, chloramnphenicol 1 %, tetracyclines 4%, erythromycin has 7%, market.

Antibiotics Conferences | Antibiotics Meetings | Antibiotic Resistance Conferences | Antibiotics 2019 Conferences

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on AntibioticsCompassion in World Farming (CIWF),

Societies in Asia and Pacific:

Australian Society of AntimicrobialsAustralasian Society for Infectious DiseasesThe Philippine Society for MicrobiologyIsrael Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

About Conference


Antibiotics 2019 invites all the participants from all over the world to attend ‘6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance' to be held on June 03-04, 2019 London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

We organize a series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Why to attend?

Antibiotics 2019 is a platform to discuss and learn about the latest advancements in the field of Antibiotics and Antibiotic Resistance as the world’s consideration turned regarding the urgency of new antibiotics as the antimicrobial resistance is growing day by day. Many developed nations and International health organizations are trying to focus of the current situation and making new policies to prevent the adverse effects of Antibiotic resistance.

The  2-day conference gathers researchers, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, young investigators, pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working in the field of Antibiotics to know the latest developments and the current situation of the Antibiotic resistance problem.

 

Past Conference Report

Antibiotics 2018

Antibiotics 2018 Report

Thanks to all of our wonderful Speakers, Conference Attendees and Collaborators; Antibiotics 2018 Conference was our best ever!

4th World Congress and Exhibition on Antibiotics and Antibiotic Resistance hosted by Conference Series was held during June 14-15, 2018 Barcelona, Spain at TRYP BARCELONA AEROPUERTO with the theme “A New Era in Antibiotics drug development” which got splendid response. With the support and guidance of Organizing Committee Members and Editorial Board Members and astonishing presentations of all participants this prominent event became more impressive.

Conference Series would like to convey a great appreciation to following eminent people, Organizing Committee Members and Keynote speakers.

Organizing Committee Members:

John J.S. Cadwell, FiberCell Systems Inc, USA

Mario A. Bianchet, Johns Hopkins School of Medicine, USA

Reza Nassiri, Michigan State University, USA

Marek Cyprian Chmielewski, The Polish Academy of Sciences, Poland

Bernhard R. Ruf, Klinikum St. Georg gGmbH, Germany         
 

Keynote speakers

Mario A. Bianchet, Johns Hopkins School of Medicine, USA

Marek Cyprian Chmielewski, The Polish Academy of Sciences, Poland

Roberto Grau, Universidad Nacional de Rosario, Argentina

María Rosa Chaig, Bioquímica y Biología Molecular, Argentina          
 

Organizing Committee Members and Keynote Speakers who supported for the success of this event with sustainable excitement for grand success of this prominent conference it is glad to announce next annual meeting 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance from June 03-04, 2019 London, UK with the theme “Challenges and new concepts in antibiotics research”.

We hope your favourable support will make next annual also one more grand success event.

Present and Exhibit your research work @London

 


Past Reports  Gallery  

Antibiotics 2017

Antibiotics 2017 Report

Conference Series hosted the “3rd World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2017) during July 31-August 01, 2017 at Hilton Garden Inn Milan North, Milan, Italy.

Antibiotics 2017 is specifically premeditated with a unifying axiom providing platform to widen the imminent scientific discoveries in the field of Antibiotics and Antibiotic Resistance and to deliver novel ideas besides incorporating better understanding of their role in Pharma, Drug Manufacturers, Business Management and Marketing. The scientific meeting has laid the path for the development and the validation of Antibiotics and Antibiotic Resistance under the theme of “The Future Of Antibiotics: Key Opportunities & Emerging Therapies”.

The conference invited Scientific Professionals, Researchers and Corporate Leaders from diverse disciplines emphasizing the areas of types & approaches for Antibiotic Treatment, The Emergence of Antimicrobial Resistance, Antibiotic Resistance: Opportunities and Challenges, Antibiotics for Emerging and Re-emerging Diseases, Antibiotic Prophylaxis etc.

 Conference Series is prerogative to thank the Organizing Committee, Editorial Board Members and Moderator – Dr. Siham M.Mahgoub, Alzahra Hospital Dubai, UAE, speaker participants, poster presenters and attendees for enormous support and participation in this grand venture.

The highlights of the meeting were the eponymous lectures, delivered by the following speakers:

Byungse Suh, Temple University School of Medicine, USA

Hartmut Derendorf, University of Florida, USA

Surbhi Malhotra Kumar, University of Antwerp, Belgium

Tadashi Shimamoto, Hiroshima University, Japan

Samir Kumar-Singh, University of Antwerp, Belgium

Siham M.Mahgoub, Alzahra Hospital Dubai

By the endless support of the Journal of Drug Metabolism & Toxicology, Advances in Pharmacoepidemiology & Drug Safety, Drug Designing: Open Access and Advances in Antibiotics & Antibodies. Conference Series is pleased to announce our 4th World Congress & Exhibition on Antibiotics & Antibiotic Resistance, during June 14-15, 2018 at Barcelona, Spain.

Let us meet @ Antibiotics 2018

 

Past Reports  Gallery  

Antibiotics 2016

Antibiotics 2016 Report

Conference Series hosted the “2nd World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2016) during October 13-15, 2016 at Radisson BLU Hotel, Manchester Airport, Manchester, UK.

Antibiotics 2016 is specifically premeditated with a unifying axiom providing platform to widen the imminent scientific discoveries in the field of Antibiotics and Antibiotic Resistance and to deliver novel ideas besides incorporating better understanding of their role in Pharma, Drug Manufacturers, Business Management and Marketing. The scientific meeting has laid the path for the development and the validation of Antibiotics and Antibiotic Resistance under the theme of “Underlining the Hurdles Involved in Developing New Antibiotics”.

The conference invited Scientific Professionals, Researchers and Corporate Leaders from diverse disciplines emphasizing the areas of types & approaches for Antibiotic Treatment, The Emergence of Antimicrobial Resistance, Antibiotic Resistance: Opportunities and Challenges, Antibiotics for Emerging and Re-emerging Diseases, Antibiotic Prophylaxis etc.

Antibiotics 2016 was privileged to acquire support from exhibitors - Radiometer Limited and BioSystems Technology.

 Conference Series is prerogative to thank the Organizing Committee, Editorial Board Members and Moderator – Dr. Oleg Reva, University of Pretoria, South Africa, speaker participants, poster presenters and attendees for enormous support and participation in this grand venture.

The highlights of the meeting were the eponymous lectures, delivered by the following speakers:

Byungse Suh, Temple University School of Medicine, USA

Mario A Bianchet, Johns Hopkins School of Medicine, USA

Herbert B Allen, Drexel University, USA

Andrew Cross, ACT Surfaces Ltd, UK

Samir Kumar-Singh, University of Antwerp, Belgium

By the endless support of the Journal of Drug Metabolism & Toxicology, Advances in Pharmacoepidemiology & Drug Safety, Drug Designing: Open Access and Advances in Antibiotics & Antibodies. Conference Series is pleased to announce our 3rd World Congress on Antibiotics & Antibiotic Resistance, during July 31-August 02, 2017 at Milan, Italy.

Let us meet again @ Antibiotics 2017

 

Past Reports  Gallery  

Antibiotics-2015

Antibiotics 2015 Report

Conference Series hosted the “2nd World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2016) during October 13-15, 2016 at Radisson BLU Hotel, Manchester Airport, Manchester, UK.

Antibiotics 2016 is specifically premeditated with a unifying axiom providing platform to widen the imminent scientific discoveries in the field of Antibiotics and Antibiotic Resistance and to deliver novel ideas besides incorporating better understanding of their role in Pharma, Drug Manufacturers, Business Management and Marketing. The scientific meeting has laid the path for the development and the validation of Antibiotics and Antibiotic Resistance under the theme of “Underlining the Hurdles Involved in Developing New Antibiotics”.

The conference invited Scientific Professionals, Researchers and Corporate Leaders from diverse disciplines emphasizing the areas of types & approaches for Antibiotic Treatment, The Emergence of Antimicrobial Resistance, Antibiotic Resistance: Opportunities and Challenges, Antibiotics for Emerging and Re-emerging Diseases, Antibiotic Prophylaxis etc.

Antibiotics 2016 was privileged to acquire support from exhibitors - Radiometer Limited and BioSystems Technology.

 Conference Series is prerogative to thank the Organizing Committee, Editorial Board Members and Moderator – Dr. Oleg Reva, University of Pretoria, South Africa, speaker participants, poster presenters and attendees for enormous support and participation in this grand venture.

The highlights of the meeting were the eponymous lectures, delivered by the following speakers:

Byungse Suh, Temple University School of Medicine, USA

Mario A Bianchet, Johns Hopkins School of Medicine, USA

Herbert B Allen, Drexel University, USA

Andrew Cross, ACT Surfaces Ltd, UK

Samir Kumar-Singh, University of Antwerp, Belgium

By the endless support of the Journal of Drug Metabolism & Toxicology, Advances in Pharmacoepidemiology & Drug Safety, Drug Designing: Open Access and Advances in Antibiotics & Antibodies. Conference Series is pleased to announce our 3rd World Congress on Antibiotics & Antibiotic Resistance, during July 31-August 02, 2017 at Milan, Italy.

Let us meet again @ Antibiotics 2016

 

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 03-04, 2019

Speaker Opportunity

Past Conference Report

Supported By

Advances in Antibiotics & Antibodies Drug Designing: Open Access Advances in Pharmacoepidemiology & Drug Safety Journal of Drug Metabolism & Toxicology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by